https://www.selleckchem.com/pr....oducts/cordycepin.ht
Median follow-up was 72 weeks. Fewer women than men had HIV-1 RNA ≤200copies/mLat week 48 39% vs 49% in cohort A and 83% vs 89% in CohortsB, C and D combined. More women experienced VF, Grade ≥3 signs and symptoms, but similar Grade ≥3 diagnoses or laboratory abnormalities. CONCLUSION More women than men entered the study with a resistance profile suggesting that their second-line regimen could have been effective in maintaining virologic suppression. The more frequent occurrence of Grade≥3 signs and symptoms in women suggests that t
Like
Comment
Share
